September 4, 2024

World Duchenne Day is on September 7th: Spreading Rare Disease Awareness (Patient Worthy)

August 30, 2024

Disco-Themed Gala In Austin For CureDuchenne Gets 70s Cool (Curated Texan)

August 1, 2024

Champions for a Cause (Aventura Magazine)

August 23, 2024

Here & Now: CureDuchenne (Fox 4 Dallas)

August 23, 2024

Despite Expanded Approval of DMD Gene Therapy, Few Outside the US Have Access (Rare Disease Advisor)

August 13, 2024

New Phase 1/2 EXPLORE44 Trial Data Shows Continued Treatment Effect of AOC 1044 in Duchenne Muscular Dystrophy (NeurologyLive)

August 8, 2024

In their own words: Personal journeys through DMD treatment (Muscular Dystrophy News Today)

August 1, 2024

Identifying Drug Development Opportunities for DMD with CureDuchenne (Cell & Gene)

July 25, 2024

New study may help more DMD patients be included in clinical trials (Muscular Dystrophy News)

July 24, 2024

Alongside Gene Therapy, Exon Skipping Remains Key Target in Duchenne Research (Rare Disease Advisor)

July 24, 2024

cTAP Study Indicates Duchenne Muscular Dystrophy Clinical Trial Enrollment Criteria Should Expand Beyond Ambulatory Status (BioSpace)

July 19, 2024

NHL All-Star Ryan Getzlaf Hosts 13th Annual Getzlaf Golf Shootout Sept. 13 – 14 to Benefit CureDuchenne (Newport Beach Independent)

July 10, 2024

Local Honor Roll Student & Family Share About Duchenne Muscular Dystrophy (Orlando Magazine)

June 21, 2024

US FDA approves expanded use of Sarepta’s Duchenne gene therapy; shares jump (Reuters)

June 21, 2024

Elevidys DMD gene therapy now FDA-approved for ages 4 and older (Muscular Dystrophy News)

June 21, 2024

US FDA approves expanded use of Sarepta’s Duchenne gene therapy; shares jump (Reuters)

June 21, 2024

FDA Grants Traditional Approval to Elevidys Gene Therapy for Ambulatory DMD, Accelerated Approval for Nonambulatory Patients (NeurologyLive)

June 17, 2024

Sarepta Looks to Expand New Gene Therapy to More Patients With DMD (Rare Disease Advisor)

June 17, 2024

Being active with DMD: Physical therapy and exercise (Muscular Dystrophy News)

May 24, 2024

At CureDuchenne Futures, Panel Marks Both Triumph and Tragedy in Gene Therapy Race (Rare Disease Advisor)

May 24, 2024

With Duchenne decision ahead, FDA’s Marks pushes for speedy gene therapy approvals (BioPharma Dive)

May 17, 2024

Nueva oportunidad de vida para dos pequeños en Texas (Telemundo Dallas)